Guru Ownership Trend
Guru Analysis for Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $662.61 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $145.32 M net inflow during the quarter.
Recent activity highlights Jefferies Group who dramatically increased their stake. Conversely, HOTCHKIS & WILEY reduced exposure by 78.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Jazz Pharmaceuticals plc (JAZZ)
Major holders include Cliff Asness ($249.86 M), Renaissance Technologies (RenTech) ($154.9 M), Steven Cohen ($67.8 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 2.87 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $145.32 M, with 6 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited JAZZ. The total reported sell value was $25.95 M.
Yes, 2 managers opened new positions in JAZZ, and 4 increased their existing holdings. The total reported buy value was $171.28 M.
